Patel Gautam
SEC insider (Form 3/4/5 filer). CIK 0001738054. Director at ANAVEX LIFE SCIENCES CORP. (AVXL) and 2 other issuers. 16 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in NEW YORK, NY.
Companies Patel Gautam has filed insider reports for
- ANAVEX LIFE SCIENCES CORP. (AVXL): Director
- Amneal Pharmaceuticals, Inc. (AMRX): Director
- Spectrum Brands Holdings, Inc. (SPB): Director
Patel Gautam
CIK: 0001738054
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Aug 10, 2026AMRX
Amneal Pharmaceuticals, Inc.
AwardIndirect283.6K shares- - May 7, 2026AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect34.8K shares- - May 6, 2026AMRX
Amneal Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
19.8K shares- - Dec 12, 2025SPB
Spectrum Brands Holdings, Inc.
AwardDirect4.6K shares- - Jun 16, 2025AMRX
Amneal Pharmaceuticals, Inc.
SaleDirect94.9K shares at avg. $8.02$761K - Jun 10, 2025AMRX
Amneal Pharmaceuticals, Inc.
SaleDirect56.4K shares at avg. $8.02$453K - May 6, 2025AMRX
Amneal Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
34.8K shares- - May 5, 2025AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect40.3K shares- - May 5, 2025AMRX
Amneal Pharmaceuticals, Inc.
SaleDirect4.9K shares at avg. $8.00$39K - May 2, 2025AMRX
Amneal Pharmaceuticals, Inc.
SaleDirect3.8K shares at avg. $8.00$30K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 |  AMRX Amneal Pharmaceuticals, Inc. | Award | 283,632 | - | $0 | Indirect |
| May 7, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise | 34,819 | - | $0 | Direct |
| May 6, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award Restricted Stock Units | 19,824 | - | - | Direct |
| Dec 12, 2025 |  SPB Spectrum Brands Holdings, Inc. | Award | 4,602 | - | - | Direct |
| Jun 16, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Sale | 94,906 | $8.02 | $761,146 | Direct |
| Jun 10, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Sale | 56,426 | $8.02 | $452,537 | Direct |
| May 6, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Award Restricted Stock Units | 34,819 | - | - | Direct |
| May 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Exercise | 40,258 | - | - | Direct |
| May 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Sale | 4,900 | $8.00 | $39,200 | Direct |
| May 2, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Sale | 3,768 | $8.00 | $30,144 | Direct |
1-10 of 16 transactions